clinical trial · NCT00476437
Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.
Novo Nordisk A/S·phase3·completed·n = 81
DiabetesDiabetes Mellitus, Type 2biphasic insulin aspartbiphasic human insulin
brief summary
This trial is conducted in Japan. The purpose of this trial is to investigate the safety and the effect of biphasic insulin aspart 50 compared to biphasic human insulin 50 in patients with type 2 diabetes mellitus.
started
Apr 1, 2007
primary completion
Nov 1, 2007
completion
Nov 1, 2007
last updated
Nov 2, 2023
official title
Safety and Effect of Biphasic Insulin Aspart 50 Compared to Biphasic Human Insulin 50 in Patients With Type 2 Diabetes Mellitus.
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol